I.Ceram SA
I.CERAM SA designs, manufactures, and markets alumina-based ceramic implants in France and internationally. It offers implants for various joints of the human body, including skull, spine, hip, tibia, ankle, foot, and thorax, as well as osteosynthesis products. The company was incorporated in 2005 and is headquartered in Limoges, France. I.CERAM SA is a subsidiary of Investissement Développement.
I.Ceram SA (ALICR) - Net Assets
Latest net assets as of June 2024: €431.78K EUR
Based on the latest financial reports, I.Ceram SA (ALICR) has net assets worth €431.78K EUR as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€3.91 Million) and total liabilities (€3.48 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €431.78K |
| % of Total Assets | 11.05% |
| Annual Growth Rate | 32.8% |
| 5-Year Change | -78.46% |
| 10-Year Change | -47.53% |
| Growth Volatility | 882.49 |
I.Ceram SA - Net Assets Trend (2012–2023)
This chart illustrates how I.Ceram SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for I.Ceram SA (2012–2023)
The table below shows the annual net assets of I.Ceram SA from 2012 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €890.00K | -55.92% |
| 2022-12-31 | €2.02 Million | +8.95% |
| 2021-12-31 | €1.85 Million | -29.03% |
| 2020-12-31 | €2.61 Million | -36.79% |
| 2019-12-31 | €4.13 Million | -40.47% |
| 2018-12-31 | €6.94 Million | +6.54% |
| 2017-12-31 | €6.51 Million | -26.02% |
| 2016-12-31 | €8.81 Million | -17.23% |
| 2015-12-31 | €10.64 Million | +527.25% |
| 2014-12-31 | €1.70 Million | +36.64% |
| 2013-12-31 | €1.24 Million | +3057.76% |
| 2012-12-31 | €39.31K | -- |
Equity Component Analysis
This analysis shows how different components contribute to I.Ceram SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 65521300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €590.91K | 66.39% |
| Other Comprehensive Income | €339.64K | 38.16% |
| Other Components | €1.04 Million | 116.91% |
| Total Equity | €890.00K | 100.00% |
I.Ceram SA Competitors by Market Cap
The table below lists competitors of I.Ceram SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Meshflow Acquisition Corp. Units
NASDAQ:MESHU
|
$95.31K |
|
SHEKF
OTCGREY:SHEKF
|
$95.33K |
|
CAFLX
NASDAQ:CAFLX
|
$95.34K |
|
Xsolla SPAC 1 Units
NASDAQ:XSLLU
|
$95.34K |
|
DRAX GROUP
BE:D9F2
|
$95.24K |
|
United Breweries Co Inc
STU:CVU
|
$95.21K |
|
3billion
KQ:394800
|
$95.21K |
|
Lithos Energy Ltd.
OTCQB:LITSF
|
$95.20K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in I.Ceram SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 2,019,271 to 890,000, a change of -1,129,271 (-55.9%).
- Net loss of 1,103,568 reduced equity.
- Other comprehensive income decreased equity by 25,701.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-1.10 Million | -124.0% |
| Other Comprehensive Income | €-25.70K | -2.89% |
| Other Changes | €-2.00 | -0.0% |
| Total Change | €- | -55.92% |
Book Value vs Market Value Analysis
This analysis compares I.Ceram SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.13x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.92x to 0.13x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | €0.21 | €0.40 | x |
| 2013-12-31 | €6.61 | €0.40 | x |
| 2014-12-31 | €7.72 | €0.40 | x |
| 2015-12-31 | €39.67 | €0.40 | x |
| 2016-12-31 | €33.38 | €0.40 | x |
| 2017-12-31 | €24.15 | €0.40 | x |
| 2018-12-31 | €23.73 | €0.40 | x |
| 2019-12-31 | €14.13 | €0.40 | x |
| 2020-12-31 | €8.93 | €0.40 | x |
| 2021-12-31 | €6.34 | €0.40 | x |
| 2022-12-31 | €6.93 | €0.40 | x |
| 2023-12-31 | €3.04 | €0.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently I.Ceram SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -124.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -111.29%
- • Asset Turnover: 0.26x
- • Equity Multiplier: 4.35x
- Recent ROE (-124.00%) is below the historical average (-122.29%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -1004.66% | -31.12% | 0.39x | 82.41x | €-398.86K |
| 2013 | -26.37% | -24.32% | 0.39x | 2.75x | €-451.45K |
| 2014 | 3.10% | 3.82% | 0.35x | 2.30x | €-117.04K |
| 2015 | -9.47% | -70.81% | 0.11x | 1.23x | €-2.06 Million |
| 2016 | -21.57% | -126.05% | 0.13x | 1.27x | €-2.78 Million |
| 2017 | -33.13% | -145.90% | 0.15x | 1.47x | €-2.81 Million |
| 2018 | -37.93% | -176.72% | 0.16x | 1.38x | €-3.33 Million |
| 2019 | -66.93% | -170.24% | 0.25x | 1.60x | €-3.18 Million |
| 2020 | -58.50% | -79.02% | 0.34x | 2.19x | €-1.79 Million |
| 2021 | -41.66% | -35.89% | 0.40x | 2.92x | €-956.66K |
| 2022 | -46.38% | -66.59% | 0.28x | 2.49x | €-1.14 Million |
| 2023 | -124.00% | -111.29% | 0.26x | 4.35x | €-1.19 Million |
Industry Comparison
This section compares I.Ceram SA's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $692,380,362
- Average return on equity (ROE) among peers: -405.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| I.Ceram SA (ALICR) | €431.78K | -1004.66% | 8.05x | $95.27K |
| Crossject (ALCJ) | $1.65 Million | -647.41% | 11.18x | $105.49 Million |
| Safe Orthopaedics SA (ALSAF) | $398.00K | -1685.68% | 36.39x | $139.52K |
| Spineway (ALSPW) | $22.01 Million | -14.25% | 0.26x | $6.68 Million |
| Amplitude Surgical SAS (AMPLI) | $85.50 Million | -10.51% | 2.27x | $14.07 Million |
| EssilorLuxottica S. A. (EL) | $4.04 Billion | 14.67% | 0.88x | $61.18 Billion |
| Bonyf NV (MLBON) | $3.73 Million | -89.06% | 0.12x | $43.34K |